The Effect of Levothyroxin on Pulmonary Function Tests of Hypothyroid Patients

Authors

F Sharifi1,*, A Amari2
1Endocrine Department, Zanjan University of Medical Sciences, [email protected], IR.Iran
2Endocrine Department, Zanjan University of Medical Sciences, IR.Iran
*Corresponding Author: Endocrine Department, Zanjan University of Medical Sciences, [email protected], IR.Iran. Email: [email protected]

International Journal of Endocrinology and Metabolism:Vol. 3, issue 1; 48-51
Published online:Jan 31, 2005
Article type:Research Article
Received:Jan 01, 2004
Accepted:Feb 01, 2005
How to Cite:Sharifi F, Amari A. The Effect of Levothyroxin on Pulmonary Function Tests of Hypothyroid Patients. Int J Endocrinol Metab. 2005;3(1):. doi:

Abstract

The aim of the present study was to determine the effect of levothyroxin on the pulmonary function of patients with hypothyroidism.
Materials and Methods: In this Quaziexperimental study, all patients who were diagnosed as hypothyroid for first time and had no history of known pulmonary disease or smoking or recent abdominal or chest surgery were recruited. Levothyroxin was prescribed for all patients (1.7 Ilglkg). Spirometry was done with the standard methods for all patients at the beginning of the study and again after at least 3 months of euthyroidism.
Results: 30 patients (24 females and 6 males) with a mean age of 37.5+12 years were studied. At the beginning of the study, 16 patients had mild restrictive pulmonary abnormalities and 10 patients had moderate restrictive pulmonary disease. 4 patients were normal. At the end of the study, the results of spirometry were normal in 12 patients and mild restrictive abnormalities were found in 14, and moderate restrictive abnormalities in 4 patients. Significant increases in FEVl, FVC and FEF25-75% were found after treatment with levothroxin (p<0.05), especially in patients over 40 years of age and those with a body mass index <30 kglm2.
Conclusion:
This report shows that respiratory restrictive abnormalities are prevalent in hypothyroidism and may be reversible after treatment with levothyroxin.

Highlights

Full Text

Full text is available in PDF

Copyright

© 2005, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

30
Apr
2006

Thyroxine Therapy Improves Serum Lipoproteins and Some Clinical Findings In Patients With Subclinical Hypothyroidism

S Kalantari,
A Heidarzadeh

Kalantari S, Heidarzadeh A. Thyroxine Therapy Improves Serum Lipoproteins and Some Clinical Findings In Patients With Subclinical Hypothyroidism. Int J Endocrinol Metab. 2006;4(2):. doi:

31
Oct
2005

Comparison of Outcome in Radioiodine Induced Euthyroid and Hypothyroid Patients

F Shekholeslami,
L Ataie,
M Hedayati,
Y Mehrabi,
F Azizi

Shekholeslami F, Ataie L, Hedayati M, Mehrabi Y, Azizi F. Comparison of Outcome in Radioiodine Induced Euthyroid and Hypothyroid Patients. Int J Endocrinol Metab. 2005;3(4):. doi:

4
Aug
2025
Post-heart Surgery and Levothyroxine Therapy: A Narrative Review

Post-heart Surgery and Levothyroxine Therapy: A Narrative Review

Zeinab Sadat Mirhaghjoo,
Afagh Hassanzadeh Rad,
Sara Nikpour

Mirhaghjoo ZS, Hassanzadeh Rad A, Nikpour S. Post-heart Surgery and Levothyroxine Therapy: A Narrative Review. J Compr Ped. 2025;16(4):e161996. doi: https://doi.org/10.5812/jcp-161996

2
Jun
2013

Impact of Thyroid Dysfunction on An tioxidant Capacity, Superoxide Dismutase and Catalase Activity

Saeed Naazeri,
Mosayeb Rostamian,
Mehdi Hedayati

Naazeri S, Rostamian M, Hedayati M. Impact of Thyroid Dysfunction on An tioxidant Capacity, Superoxide Dismutase and Catalase Activity. Zahedan J Res Med Sci. 2013;16(1):. doi:

12
Oct
2019
Systemic Thyroid Hormone Status in Treated Graves’ Disease

Systemic Thyroid Hormone Status in Treated Graves’ Disease

Fereidoun Azizi,
Atieh Amouzegar,
Maryam Tohidi,
Mehdi Hedayati,
Leila Cheraghi,
Yadollah Mehrabi

Azizi F, Amouzegar A, Tohidi M, Hedayati M, Cheraghi L, et al. Systemic Thyroid Hormone Status in Treated Graves’ Disease. Int J Endocrinol Metab. 2019;17(4):e95385. doi: https://doi.org/10.5812/ijem.95385

More by these authors

F SharifiPubMedScholar
Share
Cited by
Metrics